Pharmaceutical Technology - Pharmaceutical Manufacturing & Development News & Research for Scientists

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Controlling Ice Nucleation During the Freezing Step of Lyophilization
Lyophilization technologies for controlled nucleation.
Lyophilization: A Primer
Optimized freeze-drying cycles can offer scientific and business advantages.
Prefilled Syringes or Peptide Pills?
The impact of new delivery technologies in designing peptide therapies.
Intellectual Property Battles in Solid-State Chemistry
The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms.
Enhancing Particle-Size Measurement Using Dry Laser-Diffraction Particle-Size Analysis
The author examines dry dispersion and outlines the related analytical method development.

Special 35th Anniversary Interviews, and more

USP Supply Chain Safety Videos
pharmtech corporate capabilities 2012
sponsored by
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Twitter LinkedIn
Industry Leaders: Q+A
Q&A with Stuart E. Needleman, Aptuit
A Q&A with Stuart E. Needleman, President and Chief Operating Officer of Aptuit, on recent industry trends.
Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Events
June 3, 2013 - June 6, 2013
 		World Biotechnology Congress 2013
June 4, 2013 - June 5, 2013
 		Late Stage Pharma Lifecycle Management
June 4, 2013 - June 7, 2013
 		Forum LABO & BIOTECH
The Marketplace
Regulatory Corner
Standards & Regulations
Regulatory Convergence Sought for Global Pharma Market
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
Regulatory Roundup
FDA faces budget crunch; Supreme Court hears key cases
Should Regulation of Combination Products Become More Centralized in Europe?
While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.
Fixed-Oil Excipient Monographs: Development of USP Fixed-Oil Reference Standards
This article summarizes the development and modernization of the United States Pharmacopeia-National Formulary (USP-NF) fixed-oil excipient monographs. This article contains bonus online-exclusive material.
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here